Blink Health reviews

BlinkRx’s recent decision to bring Donald Trump Jr. onto the board and take funding from anti-woke investors is nothing short of a desperate cash grab to save a struggling business. Instead of focusing on innovation and making healthcare more accessible, they’ve chosen to align with a political agenda that caters to the ultra-wealthy while alienating a significant portion of their customer base. It’s clear this isn’t about business strategy—it’s about survival at any cost. By cozying up to right-wing backers, BlinkRx has made it clear they’d rather court controversy than fix what’s actually broken in their model. This move turns what should be a healthcare service into yet another elitist club, out of touch with the people it claims to serve. If this is the direction they’re taking, count me out. I won’t support a company that prioritizes politics over patients.

Few advancement opportunities, training gaps occur and often noted by fellow colleagues. QA is very inconsistent on scoring agent calls.